Clinical Trial Update: A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures [Phase 3]

View source ↗

Summary

Phase III open-label study evaluating gabapentin as adjunctive therapy in Japanese pediatric patients with partial seizures has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsies, Partial | Phase 3 | Status: COMPLETED | Results posted: 2011-02-21